249 related articles for article (PubMed ID: 33600452)
1. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis.
Wang K; Wang Z; Zeng Q; Zhu L; Gao J; Wang Z; Zhang S; Yang F; Shen D; Wang Y; Liu Y
PLoS One; 2021; 16(2):e0245601. PubMed ID: 33600452
[TBL] [Abstract][Full Text] [Related]
2. IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study.
Lomborg N; Jakobsen M; Bode CS; Junker P
Scand J Rheumatol; 2019 Jul; 48(4):320-325. PubMed ID: 30931680
[No Abstract] [Full Text] [Related]
3. Comparison of two subsets of Chinese patients with retroperitoneal fibrosis in terms of IgG4 immunohistochemical staining.
Liao S; Zhang X; Zhu F; Wang Y; Zhu J; Zhang J; Huang F
Rheumatology (Oxford); 2019 Mar; 58(3):455-462. PubMed ID: 30476270
[TBL] [Abstract][Full Text] [Related]
4. IgG4-related retroperitoneal fibrosis: a newly characterized disease.
Lian L; Wang C; Tian JL
Int J Rheum Dis; 2016 Nov; 19(11):1049-1055. PubMed ID: 27125330
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study.
Liu Y; Zhu L; Wang Z; Zeng Q; Yang F; Gao J; Wang Z; Wang K; Ren L; Zhang Y; Zhang S; Wang Y; Shen D; Xia C; Yu G; Li Z
Rheumatology (Oxford); 2021 Feb; 60(2):767-772. PubMed ID: 32793960
[TBL] [Abstract][Full Text] [Related]
6. No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases.
Forestier A; Buob D; Mirault T; Puech P; Gnemmi V; Launay D; Hachulla E; Hatron PY; Lambert M
Clin Exp Rheumatol; 2018; 36(3):371-375. PubMed ID: 29465374
[TBL] [Abstract][Full Text] [Related]
7. Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease.
Khosroshahi A; Carruthers MN; Stone JH; Shinagare S; Sainani N; Hasserjian RP; Deshpande V
Medicine (Baltimore); 2013 Mar; 92(2):82-91. PubMed ID: 23429355
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic retroperitoneal fibrosis: a cross-sectional study of 142 Chinese patients.
Liao S; Wang Y; Li K; Zhu J; Zhang J; Huang F
Scand J Rheumatol; 2018 May; 47(3):198-205. PubMed ID: 29219671
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis.
Koo BS; Koh YW; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2015 Mar; 25(2):194-8. PubMed ID: 25036229
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics of IgG4 related retroperitoneal fibrosis: a report of 5 cases and literature review].
Dun YJ; Yu LP; Du YQ; Sheng ZZ; Wang GW; Li X; Yang B; Xu T; Huang XB; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):622-7. PubMed ID: 26284398
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis.
Wallwork R; Wallace Z; Perugino C; Sharma A; Stone JH
Medicine (Baltimore); 2018 Oct; 97(42):e12631. PubMed ID: 30334947
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics of Retroperitoneal Fibrosis Patients at a Tertiary Hospital in Japan.
Ando M; Hanayama Y; Nishimura Y; Hagiya H; Otsuka F
Acta Med Okayama; 2023 Oct; 77(5):527-536. PubMed ID: 37899264
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G4-related retroperitoneal fibrosis.
Angarola E; Valeo Chulvi M; Peuchot V; García Rivello H; Jauk F
Medicina (B Aires); 2022; 82(1):91-98. PubMed ID: 35037866
[TBL] [Abstract][Full Text] [Related]
14. Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges.
Mizushima I; Kawano M
Int J Nephrol Renovasc Dis; 2021; 14():279-289. PubMed ID: 34349543
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach.
Urban ML; Palmisano A; Nicastro M; Corradi D; Buzio C; Vaglio A
Rev Med Interne; 2015 Jan; 36(1):15-21. PubMed ID: 25455951
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic retroperitoneal fibrosis: clinical features, treatment modalities, relapse rate in Greek patients and a review of the literature.
Zampeli E; Venetsanopoulou AI; Christaki S; Argyropoulou OD; Boki KA; Manoussakis MN; Skopouli FN; Tzioufas AG; Moutsopoulos HM
Clin Exp Rheumatol; 2022 Sep; 40(9):1642-1649. PubMed ID: 34796838
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients.
Liu Y; Xue M; Wang Z; Zeng Q; Ren L; Zhang Y; Zhang S; Wang Y; Shen D; Xia C; Yu G; Li ZG
Rheumatology (Oxford); 2020 Mar; 59(3):634-640. PubMed ID: 31436287
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics of IgG4-related retroperitoneal fibrosis].
Chen H; Lin W; Yan L; Zhang H; Wu Q; Wang L; Fei Y; Su J; Wang Q; Li J; Zhang W; Tian X; Zhang X; Zhao Y; Zeng X; Zhang F
Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(39):3079-81. PubMed ID: 25549682
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease.
Choi YK; Yang JH; Ahn SY; Ko GJ; Oh SW; Kim MG; Cho WY; Jo SK
Kidney Res Clin Pract; 2019 Mar; 38(1):42-48. PubMed ID: 30754935
[TBL] [Abstract][Full Text] [Related]
20. Use of rituximab in idiopathic retroperitoneal fibrosis.
Boyeva V; Alabsi H; Seidman MA; Paterson R; Kur J; Chen LYC; Chang SD; Carruthers M
BMC Rheumatol; 2020; 4():40. PubMed ID: 32775962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
